Prof G Markets: Ozempic’s Market Impacts and ...

George Hahn connects the dots across the week's biggest stories: whether the Iran ceasefire can hold, what Britain's political turmoil says ten years after Brexit, why SpaceX is already facing a reality check, and how the World Cup is reshaping the economics of media. We’d love y ...  Show more

Scott Galloway speaks with Financial Times columnist and chief data reporter John Burn-Murdoch to unpack the forces reshaping modern life. They discuss why birth rates are collapsing, why fewer young people are forming relationships, and how housing costs, social media, and remot ...  Show more

Scott shares his thoughts on why the new Texas Stock Exchange could be an appealing choice for certain companies. He also explains how it's a symptom of a larger issue: the politicization of everything. Then Scott and Ed break down the role that short sellers have historically pl ...  Show more

Real Vision senior editor Ash Bennington hosts managing editor Ed Harrison to discuss the animal spirits that are driving this market. After reviewing historical financial panics, Ed and Ash take another look at whether options mania is exerting influence on equity price action. ...  Show more

A strong session for stocks send the averages to a positive week; 3Fourteen Research’s Warren Pies and Unlimited Funds CIO Bob Elliott break down the wild week of earnings and what’s ahead for next week. Well-known JPMorgan analyst Stephen Tusa talks his bullishness on an unde ...

Investors are awaiting the kickoff to this week's Fed decision. The Milken Institute's Bill Lee gives his expectations. Plus, Amazon and Apple are set to deliver results in what could be two market-moving events. Janus Henderson's Alison Porter explains. And, it's busiest week ...